0001209191-21-002632.txt : 20210107 0001209191-21-002632.hdr.sgml : 20210107 20210107202609 ACCESSION NUMBER: 0001209191-21-002632 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210101 FILED AS OF DATE: 20210107 DATE AS OF CHANGE: 20210107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cappel Markus J. CENTRAL INDEX KEY: 0001422995 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35420 FILM NUMBER: 21515309 MAIL ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ChemoCentryx, Inc. CENTRAL INDEX KEY: 0001340652 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943254365 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650-210-2900 MAIL ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-01 0 0001340652 ChemoCentryx, Inc. CCXI 0001422995 Cappel Markus J. C/O CHEMOCENTRYX, INC. 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 0 1 0 0 Chief Bus. Officer & Treasurer Common Stock 2021-01-01 4 M 0 6667 0.00 A 82914 D Common Stock 2021-01-01 4 M 0 6667 0.00 A 89581 D Common Stock 2021-01-01 4 M 0 7766 0.00 A 97347 D Common Stock 2021-01-01 4 F 0 11521 61.92 D 85826 D Restricted Stock Units 2021-01-01 4 M 0 6667 D Common Stock 6667 0 D Restricted Stock Units 2021-01-01 4 M 0 6667 D Common Stock 6667 6667 D Restricted Stock Units 2021-01-01 4 M 0 7766 D Common Stock 7766 15534 D Shares were acquired upon vesting of restricted stock units awarded on March 5, 2018. Shares were acquired upon vesting of restricted stock units awarded on March 4, 2019. Shares were acquired upon vesting of restricted stock units awarded on March 3, 2020. Represents shares withheld upon vesting of restricted stock units to satisfy tax withholding obligation. Each restricted stock unit represents a contingent right to receive one share of CCXI common stock. The restricted stock units awarded on March 5, 2018, vest in three equal installments on January 1, 2019, January 1, 2020, and January 1, 2021, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date. The restricted stock units awarded on March 4, 2019, vest in three equal installments on January 1, 2020, January 1, 2021, and January 1, 2022, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date. The restricted stock units awarded on March 3, 2020, vest in three equal installments on January 1, 2021, January 1, 2022, and January 1, 2023, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date. /s/ Susan M. Kanaya, as Attorney-in-Fact 2021-01-07